Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anterix Inc.ATEX · Entity 4597 | Director · President and CEO | August 23, 2024 | August 26, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anterix Inc.
Report date August 23, 2024 · Filed August 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,867 |
Reported balance
After 2024-08-23 transaction · row 1
1 source rowRow 1 · 2024-08-23 · Tax withholding · Disposed 6,355 · Balance 115,867 F1: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were withheld by the Issuer to satisfy withholding obligations in connection with the partial vesting and settlement of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2020 Filed Sep 3, 2020 22:40 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 7,318 | $0.00 Strike: $46.85 | $0.00 |
DisclosureSEC source: 0001209191-20-049552 · doc4.xml · derivative · entry 3 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,318 Underlying: Common Stock · 7,318 shares Expires 2025-08-29 F4 · balance_after: On February 28, 2020, the Reporting Person was granted a performance-based stock option, which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported stock option. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 22:40 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 10,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049552 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,343 F1 · shares: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 00:13 UTC | Anterix Inc. ATEX · Entity 4597 | SaleCommon Stock | 409 | $47.03 | $19,235.68 |
DisclosureSEC source: 0001209191-20-047841 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,215 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $47.00 to $47.15. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 23:19 UTC | Anterix Inc. ATEX · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 60,558 | $0.00 Strike: $49.92 | $0.00 |
DisclosureSEC source: 0001209191-20-039182 · doc4.xml · derivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,558 Underlying: Common Stock · 60,558 shares Expires 2030-06-24 F1 · derivative.exercise_date: 25% of the option shares vest and become exercisable on July 1, 2021 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| May 26, 2020 Filed May 28, 2020 22:25 UTC | Anterix Inc. ATEX · Entity 4597 | GrantCommon Stock | 4,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032710 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,624 F1 · shares: Represents the issuance of restricted stock units (the "RSUs") in lieu of a cash bonus payment the Recipient was eligible to receive pursuant to the Issuer's Short-Term Incentive Plan for services performed by the Recipient during the fiscal year ended March 31, 2020. The Issuer's Compensation Committee issued the RSUs in lieu of the cash bonus payment to help conserve the Issuer's cash resources. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:54 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 201 | $49.43 | $9,935.43 |
DisclosureSEC source: 0001209191-20-012676 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,425 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted January 2017. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 21:38 UTC | Anterix Inc. ATEX · Entity 4597 | Tax withholdingCommon Stock | 852 | $41.99 | $35,775.48 |
DisclosureSEC source: 0001209191-19-046847 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,626 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted June 2016. Read SEC document |
| May 23, 2019 Filed May 24, 2019 20:26 UTC | Anterix Inc. PDVW · Entity 4597 | Tax withholdingCommon Stock | 1,203 | $44.20 | $53,172.60 |
DisclosureSEC source: 0001209191-19-032721 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,478 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted May 2017. Read SEC document |
| May 09, 2019 Filed May 10, 2019 23:05 UTC | Anterix Inc. PDVW · Entity 4597 | GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029113 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,681 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 15, 2020 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:00 UTC | Anterix Inc. PDVW · Entity 4597 | Tax withholdingCommon Stock | 199 | $42.14 | $8,385.86 |
DisclosureSEC source: 0001209191-19-010423 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,681 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted January 2017. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 22:59 UTC | Anterix Inc. PDVW · Entity 4597 | Tax withholdingCommon Stock | 850 | $31.85 | $27,072.50 |
DisclosureSEC source: 0001209191-18-046891 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,880 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted June 2016. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 22:14 UTC | Anterix Inc. PDVW · Entity 4597 | Tax withholdingCommon Stock | 1,023 | $25.20 | $25,779.60 |
DisclosureSEC source: 0001209191-18-037081 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,730 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted May 2017. Read SEC document |
| May 14, 2018 Filed Jun 11, 2018 22:14 UTC | Anterix Inc. PDVW · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001209191-18-037081 · doc4.xml · derivative · entry 2 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-05-14 F2 · derivative.exercise_date: 50% of the option will vest and become exercisable on May 14, 2020, 25% of option will vest and become exercisable on May 14, 2021 and the remaining 25% of the option will vest and become exercisable on May 14, 2022. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 23:45 UTC | Anterix Inc. PDVW · Entity 4597 | Tax withholdingCommon Stock | 273 | $31.45 | $8,585.85 |
DisclosureSEC source: 0001209191-18-008999 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Chief Strategy & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,753 F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted January 2017. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 23:49 UTC | Anterix Inc. PDVW · Entity 4597 | Tax withholdingCommon Stock | 922 | $30.05 | $27,706.10 |
DisclosureSEC source: 0001209191-17-060452 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Chief Strategy & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,026 F1 · shares: The shares were withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted June 2016. F2 · balance_after: The aggregate number of securities beneficially owned by the Reporting Person following the reported transaction reflects a reduction of 20,000 shares of Common Stock which were incorrectly reported on Table I of the Reporting Person's Form 4 filed on August 18, 2017. On November 13, 2017, the Reporting Person filed a Form 4/A to correctly report his receipt of a stock option for 20,000 shares of Common Stock on August 17, 2017, rather than 20,000 restricted stock units as initially reported. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 22:50 UTC | Anterix Inc. PDVW · Entity 4597 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-049660 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Chief Strategy & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,948 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on August 17, 2018 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| August 17, 2017 Filed Nov 13, 2017 23:43 UTC Amendment | Anterix Inc. PDVW · Entity 4597 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001209191-17-060448 · doc4a.xml · derivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Chief Strategy & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-08-17 F1 · security: The original Form 4 Report filed on August 18, 2017 incorrectly reported the stock option as an issuance of restricted stock units on Table I. On August 17, 2017, the Reporting Person received a stock option award with an exercise price set at the closing market price of the Issuer's Common Stock on the date of grant. F2 · derivative.exercise_date: 25% of the option shares vest and become exercisable on August 17, 2018 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| May 22, 2017 Filed May 25, 2017 00:54 UTC | Anterix Inc. PDVW · Entity 4597 | GrantCommon Stock | 9,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035184 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Chief Strategy & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,948 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 22, 2018 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
| January 13, 2017 Filed Jan 18, 2017 00:01 UTC | Anterix Inc. PDVW · Entity 4597 | GrantCommon Stock | 2,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003972 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Chief Strategy & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,058 F1 · shares: Represents the issuance of restricted stock units (the "RSUs") approved by the Issuer's Compensation Committee for the Reporting Person's services. The RSUs vest and become exercisable in 4 equal annual installments beginning on January 13, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.